Prevalence of Genital HPV in US High Among Men
Genital HPV infection prevalence widespread among all age groups of men, and vaccination remains low.
HealthDay News — Nearly half of American men may be infected with human papillomavirus (HPV), and HPV vaccination coverage is low among vaccine-eligible men, according to a study published in JAMA Oncology.
Jasmine Han, MD, in the division of gynecologic oncology at the Womack Army Medical Center in Fort Bragg, North Carolina, and colleagues used data from 1868 men who took part in the 2013 to 2014 US National Health and Nutrition Examination Survey. Samples from penile swabs were tested for HPV.
The researchers found that, overall, 45.2% of the men were infected with HPV. Among vaccine-eligible men, however, only 10.7% had been vaccinated. The lowest prevalence of the virus among men was 28.9% for those aged 18 to 22, which increased to 46.5% in men aged 23 to 27 and stayed high and constant as men aged.
"The overall genital HPV infection prevalence appears to be widespread among all age groups of men, and the HPV vaccination coverage is low," the authors write. "Male HPV vaccination may have a greater effect on HPV transmission and cancer prevention in men and women than previously estimated."
Han JJ, Beltran TH, Song JW, Klaric J, Choi YS. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013-2014 [published online January 19, 2017]. JAMA Oncol. doi: 10.1001/jamaoncol.2016.6192